Pevet Pimobendan Cardiac Chews – Inodilator for Canine CHF and DCM, Including Senior Dogs (24 Tablets)

Introduction

Canine Congestive Heart Failure (CHF) and Dilated Cardiomyopathy (DCM) are serious cardiac conditions affecting dogs, particularly middle-aged to senior dogs. Left unmanaged, they severelyan Cardiac Chews** represent a scientifically formulated solution designed specifically to manage and improve cardiac function in dogs suffering from these conditions. As a dual-action inodilator, it combines inotropic (heart muscle contracting) and vasodilating (blood vessel widening) properties to enhance heart efficiency and circulation.

Mechanism of Action: Inodilator Therapy

Pimobendan, the active ingredient in Pevet Cardiac Chews (5mg per chewable tablet), works through a unique mechanism:

1. Phosphodiesterase III Inhibition: Increases intracellular cyclic adenosine monophosphate (cAMP), leading to improved calcium sensitivity within cardiac myocytes.
2. Enhanced: This potentiation results in stronger ventricular contractions without significantly increasing oxygen demand.
3. Peripheral Vasodilation: Simultaneously, it promotes vasodilation in systemic and pulmonary arterial vessels, reducing vascular resistance (afterload) and the workload on the heart. This dual action makes it a cornerstone therapy for managing CHF due to valve insufficiency and DCM.

Indications for Use

Pevet Pimobendan Cardiac Chews are indicated for:

• Treatment of Overt CHF: Specifically, congestive heart failure in dogs caused by mitral valve insufficiency, tricuspid regurgitation, or dilated cardiomyopathy (DCM).
• Treatment of Preclinical Heart Disease:
  • In Large-Breed Dogs with Preclinical DCM: Asymptomatic dogs diagnosed via echocardiography showing left ventricular dilation during systole and diastole.
  • In Dogs with Preclinical Myxomatous Mitral Valve Disease (MMVD): Asymptomatic dogs presenting with an audible left-sided systolic heart murmur and evidence of cardiac enlargement on radiographs or echocardiography. Critical Objective: To delay the onset of congestive heart failure and associated clinical symptoms.

Target Canine Population

This therapy is vital for:

• Senior dogs commonly affected by degenerative valve disease.
• Middle-aged to older large-breed dogs predisposed to DCM.
• All breeds experiencing symptomatic or high-risk preclinical heart conditions warranting targeted cardiac support.
• Dogs requiring a palatable, easy-to-administer medication format to improve long-term compliance.

Pharmacodynamics and Clinical Significance

• Acceptable Diet Management: Food can be consumed 1 hour post-administration, enhancing owner convenience.
• Compatibility: Pimobendan can be effectively combined with other essential cardiac medications, particularly diuretics like furosemide, for comprehensive CHF management. Combination therapy addresses fluid overload alongside core cardiac dysfunction.
• Long-Term Use: Pevet Pimobendan Chews are designed for chronic, continuous administration in diagnosed cases of CHF, providing sustained support.

Dosage & Administration

Precise dosing is essential for efficacy and safety:

• Dose Calculation: Administer 0.25mg pimobenzene per kilogram (kg) of the dog's body weight (0.25 mg/kg), twice daily (every 12 hours).
• Practical Dosing Guide based on Tablet Strength (5mg):
  • ~10kg Dog: Administer ½ chewable tablet (approx. 2.5mg) in both the morning and evening.
  • ~20kg Dog: Administer one whole chewable tablet (5mg) in the morning and one in the evening.
• Veterinary Oversight: Always adhere to the dosage regimen prescribed by a licensed veterinarian following thorough cardiac assessment.

Product Specifications and Packaging

• Presentation: Palatable, chewable tablets for enhanced ease of administration and compliance.
• Active Ingredient: Pimobendan (5mg per tablet).
• Pack Size: 24 tablets per kit/box.
• Bulk Carton:
  • Contains 66 kits (66 boxes) per carton.
  • Carton Dimensions: 43 cm (L) x 39 cm (W) x 18.5 cm (H).

iators of Pevet Pimobendan Cardiac Chews

1. Proven Efficacy: Targets the core pathophysiology of CHF and DCM through validated inodilator action.
2. Early Intervention Capability: Unique FDA-supported* indication for delaying CHF in preclinical stages with mitral valve disease/cardiac enlargement or DCM.
3. Palatability & Compliance: Chewable form makes precise daily dosing significantly easier for owners compared to compounded liquids or hard pills.
4. Formulation Quality: Manufactured to stringent veterinary pharmaceutical quality control standards.
5. Complementary Therapy: Designed for seamless integration into multi-drug management plans. *Note: Regulatory approvals vary by jurisdiction.

Pevet Pimobendan Cardiac Chews offer a clinically critical, convenient, and targeted therapeutic approach for managing potentially debilitating canine heart conditions like CHF due to valve disease or DCM. By improving cardiac contractility and reducing afterload, it helps alleviate symptoms in affected dogs and significantly delays disease progression in high-risk preclinical patients. Prioritize veterinary-prescribed cardiac health management. Ensure your clinic or inventory includes this essential inodilator therapy to effectively serve dogs battling heart failure. Contact us today for product specifications, pricing, and ordering protocols to enhance your cardiac care offering.

TKD Information (Title Tag, Meta Keywords, Meta Description):

• Title: Pevet Pimobendan Chewable Tablets for Canine CHF & DCM Treatment - Inodilator | 5mg, 24 Chews
• Meta Keywords:
  • Pimobendan Chewable Tabs Canine
  • Dog Heart Failure Medication
  • CHF Therapy for Dogs
  • DCM Treatment Canine
  • Veterinary Inodilator Pimobendan
  • Mitral Valve Disease Treatment
  • Heart Medicine for Older Dogs
  • Digoxin Alternative CHF
  • 5mg Pimobendan Tablets
  • Palatable Cardiac Chews Dogs
• Meta Description: Veterinary-approved Pevet Pimobendan 5mg Chewable Tabs manage Canine CHF (valve disease/DCM) & delay progression. Inodilator for stronger heart function & vessel relaxation. 24 Chews. For owners/vets.